首页|阿法替尼脂质体冻干粉的制备与性质

阿法替尼脂质体冻干粉的制备与性质

扫码查看
设计一种新型脂质体冻干粉,作为吸入剂有望解决阿法替尼因口服给药产生的胃肠道不良反应等问题,发挥局部定位治疗效果.根据外观形态、溶解性、粒径和包封率确定最佳冻干工艺,并对制备的冻干粉性质进行表征.实验结果显示,采用冷冻干燥法制备的以甘露醇+乳糖为联合冻干保护剂的阿法替尼脂质体冻干粉为白色蓬松粉末,溶解性好,略有引湿性,流动性好,复溶后的平均粒径为(167.0±3.7)nm,包封率为(91.3± 1.2)%,稳定性较好.体外释放实验表明,该制剂在PBS和含20%FBS的PBS中初始阶段释放较为缓慢,48 h释放率均为60%左右.体外细胞毒性实验表明,阿法替尼脂质体冻干粉与阿法替尼脂质体的肿瘤细胞毒性作用相当,IC50值为(4.9±0.6)μg/mL.
Preparation and Properties of Afatinib Liposome Freeze-Dried Powder
A novel liposomal freeze-dried powder designed as an inhalation agent is expected to solve the problems such as severe gastrointestinal adverse effects of afatinib due to oral administration.The optimal lyophilization process is determined based on the appearance morphology,solubility,particle size,and encapsulation rate,and the properties of the prepared lyophilized powder are characterized.The experimental results show that afatinib lipo-somal freeze-dried powder prepared by freeze-drying method with mannitol+lactose as combined lyophilization pro-tectant is a fluffy white powder with good solubility,slight moisture attraction and good fluidity.The average parti-cle size after re-dissolution is(167.0±3.7)nm,the encapsulation rate is(91.3±1.2)%,and the stability is good.In vitro release experiments show that the preparation is released slowly in PBS and PBS containing 20%FBS at the initial stage,and its release rate is about 60%at 48 h.In vitro cytotoxicity test shows that the tumor cytotox-icity of the freeze-dried powder of afatinib liposome is similar to that of afatinib liposome,with the IC50 value of(4.9±0.6)µg/mL.

non-small cell lung cancerafatinib liposomefreeze-dried powderfreeze dryinglyophilized pro-tectant

朱效素、王晓雯、王玉、梁涪淮、张蓬、于晓锋、刘沙

展开 >

烟台大学药学院,分子药理和药物评价教育部重点实验室(烟台大学),新型制剂与生物技术药物研究山东省高校协同创新中心,山东烟台 264005

烟台毓璜顶医院,山东烟台 264000

非小细胞肺癌 阿法替尼脂质体 冻干粉 冷冻干燥 冻干保护剂

国家自然科学基金烟台市科技发展项目

820019612022YD037

2024

烟台大学学报(自然科学与工程版)
烟台大学

烟台大学学报(自然科学与工程版)

影响因子:0.373
ISSN:1004-8820
年,卷(期):2024.37(1)
  • 12